With the recent launch of a product to evaluate artificial intelligence (AI) models for accuracy and susceptibility to bias, Mayo Clinic Platform is accelerating adoption of data-driven innovation in clinical practice.

Mayo Clinic Platform_Accelerate has announced its second cohort of health tech startups, including national and international businesses. The program will help seven companies develop and validate their artificial intelligence-driven health care products or solutions and advance their business plans.

This collaboration will create an environment that enables rapid product development in the U.S. and Israeli markets, allowing technologies to be established and launched to transform health care delivery for all.

Mayo Clinic Platform_Accelerate, an immersive program for health tech startups, has launched with its initial cohort of participating companies. The 20-week program will help four artificial intelligence (AI) companies get market-ready.